Literature DB >> 30882312

Seroprevalence of Borrelia burgdorferi, B. miyamotoi, and Powassan Virus in Residents Bitten by Ixodes Ticks, Maine, USA.

Robert P Smith, Susan P Elias, Catherine E Cavanaugh, Charles B Lubelczyk, Eleanor H Lacombe, Janna Brancato, Hester Doyle, Peter W Rand, Gregory D Ebel, Peter J Krause.   

Abstract

We conducted a serosurvey of 230 persons in Maine, USA, who had been bitten by Ixodes scapularis or I. cookei ticks. We documented seropositivity for Borrelia burgdorferi (13.9%) and B. miyamotoi (2.6%), as well as a single equivocal result (0.4%) for Powassan encephalitis virus.

Entities:  

Keywords:  Borrelia burgdorferi; Borrelia miyamotoi; Ixodes scapularis; Maine; POWV; Powassan virus; United States; bacteria; deer ticks; meningitis/encephalitis; seroprevalence; tick bites; ticks; vector-borne infections; viruses; zoonoses

Mesh:

Year:  2019        PMID: 30882312      PMCID: PMC6433028          DOI: 10.3201/eid2504.180202

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Reports of Lyme disease in Maine, USA, have increased from a few cases in the late 1980s to 1,848 cases in 2017 (), coinciding with range expansion of Ixodes scapularis ticks over the past 3 decades (). The Maine Center for Disease Control reported the first 2 cases of hard-tick relapsing fever caused by Borrelia miyamotoi during 2016 and an additional 6 cases during 2017 (). Hard-tick relapsing fever typically manifests as a nonspecific febrile illness (,). Han et al. () found a B. miyamotoi infection prevalence of 3.7% in adult I. scapularis ticks in Maine, ≈10-fold less than that for B. burgdorferi infection (50%, range 32%–65%) (). Powassan virus (POWV) encephalitis can have devastating complications and has infected 10 residents of Maine during 2000–2017. There are 2 variants of POWV with distinct enzootic cycles and tick vectors. Lineage 1 is transmitted by I. cookei ticks and lineage 2, sometimes referred to as deer tick virus, is transmitted by I. scapularis ticks (). Both lineages are present in Maine (), but lineage 1 has a lesser risk for transmission because human bites by I. cookei ticks are infrequent (). One fatal Maine case was demonstrated to be caused by lineage 2 POWV (). Although POWV infection prevalence in Maine I. scapularis ticks is low (0.7%–1.8%) (), frequent exposure to I. scapularis bites () and rapidity of POWV transmission (i.e., POWV can be transmitted to vertebrates after only 15 min from onset of the tick bite) () raise concern. Our objective was to determine the seroprevalence of B. burgdorferi, B. miyamotoi, and POWV to clarify the frequency of exposure to each of these pathogens in resi-dents of Maine, USA, who had been bitten by I. scapularis or I. cookei ticks. We also anticipated that a serosurvey might provide evidence of asymptomatic POWV infection or self-limited illness in a few persons, as reported elsewhere (,).

The Study

The Vector-Borne Disease Laboratory of the Maine Medical Center Research Institute provided a free, statewide tick identification service during 1989–2013 to monitor exposure to I. scapularis ticks during range expansion of this invasive vector of human and animal disease. Persons submitted ticks that they had removed from themselves, family members, and pets. As of 2014, 33,332 ticks representing 14 species were identified in Maine; I. scapularis ticks were predominant. During 2014, we used our tick identification service database () to identify persons who had removed >1 attached I. scapularis or I. cookei tick(s) in the previous 5 years (2009–2013). We invited these persons to participate in a serosurvey to assess past exposure to B. burgdorferi, B. miyamotoi, and POWV. Family members who attended the clinic with these persons and who reported being bitten by ticks were also invited to participate. The study was approved by Maine Medical Center Institutional Review Board (Protocol #4222). Participants provided informed consent (assent for minors) and submitted 30 mL of blood. Blood was centrifuged at 3,500 rpm for 15 min. Serum aliquots were stored at −20°C and then shipped to testing laboratories. Serologic testing for antibodies to B. miyamotoi was conducted at the laboratory of one of the authors (P.J.K.). An ELISA and confirmatory Western blot assay were used to detect serum reactivity to B. miyamotoi GlpQ protein (). For the ELISA, serum samples were diluted 1:320 and a signal >3 SD above the mean of 3 B. miyamotoi–negative serum controls was considered positive for B. miyamotoi antibody. Serum samples were considered B. miyamotoi seropositive if ELISA IgG and Western blot IgG tests yielded positive results. Serologic evidence of exposure to B. burgdorferi was detected by the standard 2-step ELISA and Western blot assay in the L2 Diagnostic Laboratory at Yale School of Medicine by one of the authors (H.D.). A reactive serum was defined as one that reacted to a dilution >1:100. All borderline or reactive serum was further characterized by Western blot immunoassay. Specimens were considered positive for B. burgdorferi exposure if the IgG immunoblot contained >5 of the 10 most common B. burgdorferi–associated bands (). Serologic testing for POWV was conducted by one of the authors (G.D.E.) by using a plaque-reduction neutralization test (PRNT) and a POWV–West Nile virus (WNV) chimeric virus (POWV–premembrane–envelope [prME]/WNV) assay as described (). The specificity of the assay was determined by cross-neutralization studies, which demonstrated that antiserum raised against POWV efficiently neutralized chimeric POWV–prME/WNV but not WNV and that antiserum raised against WNV did not neutralize POWV–prME/WNV (). Use of the chimeric POWV–prME/WNV assay virus enabled PRNT testing to be conducted on African green monkey kidney (Vero) cells according to standard procedures by using a 90% neutralization cutoff to be considered positive (). Of 230 enrolled persons, 190 were in our tick identification program database, and 40 were family members (Table 1). Among the 190 persons, 1 tick bite was from an I. cookei nymph, 13% of bites were from I. scapularis nymphs, and 86% of bites were from I. scapularis adult females. Engorgement of ticks ranged from slight (43%) to moderate (38%) to high (18%). Among the study population, 32 (13.9%) were seropositive for B. burgdorferi, 6 (2.6%) were seropositive for B. miyamotoi, and 2 (0.9%) were seropositive for both pathogens (Table 2). The serum of 1 person (0.4%) neutralized POWV at a titer of 1:20 and WNV at a titer of 1:10. We designated this serum as flavivirus positive. This person reported a history of neurologic illness for >1 year and a tick bite within the study year.
Table 1

Characteristics of residents bitten by blacklegged (deer) ticks (Ixodes scapularis) during 2009 and 2013 who participated in a serosurvey for antibodies against Borrelia burgdorferi, B. miyamotoi, and Powassan virus, Maine, USA, 2014*

CharacteristicNo. (%) residents
Mailings and responses
No. persons mailed1,253
No. persons attending a clinic230
No. database persons190
No. persons from families of database persons
40
Clinic information
Location
Biddeford clinics: April 23 and 26, 21 towns31 (13.5)
Ellsworth clinics: Apr 18 and 19, 34 towns94 (40.9)
Rockland clinics: Apr 5 and 18, 21 towns32 (13.9)
Scarborough clinics: Apr 10 and 12, 36 towns
73 (31.7)
Tick bite history and demographics of persons in database

Year tick submitted
200927 (14.2)
201041 (21.6)
201147 (24.7)
201237 (19.5)
2013
38 (20.0)
Tick species/stage
Ixodes cookei nymph1 (0.5)
Ix. scapularis female164 (86.3)
Ix. scapularis nymph
25 (13.2)
Tick engorgement
Slight82 (43.2)
Moderate73 (38.4)
Heavy
35 (18.4)
Age, y, at time of bite
Adults, range 19–84168 (88.4)
Children, range 6–18
22 (11.6)
Sex
M88 (46.3)
F
102 (53.7)
Demographics of all persons at time of clinic visit
Age, y
Adults, range 18–90215 (93.0)
Children, range 8–1715 (7.0)
Race
Not reporting3 (1.3)
American Indian/Alaska Native0 (0.0)
Asian2 (0.9)
Black or African American0 (0.0)
Hispanic or Latino1 (0.4)
Native Hawaiian/Pacific Islander0 (0.0)
White224 (98.7)
Sex
M107 (46.5)
F123 (53.5)

*Database persons refers to tick-bitten persons who had submitted their ticks to a tick identification program in Maine. Family of database persons were database person family members who reported being bitten by a blacklegged tick during 2009–2013.

Table 2

Seropositivity of tick-bitten persons for Borrelia burgdoferi, B. miyamotoi, and Powassan virus, Maine, USA, 2014*

Pathogen, antibody test resultNo. (%) database persons, n = 190No. (%) family of database persons, n = 40No. (%) total, n = 230
B. burgdorferi
Positive26 (13.7)6 (15.0)32 (13.9)
Negative
164 (86.3)
34 (85.0)
198 (86.1)
B. miyamotoi
Positive4 (2.1)2 (5.0)6 (2.6)
Negative
186 (97.9)
38 (95.0)
224 (97.4)
B. burgdorferi/B. miyamotoi
Positive2 (1.1)02 (0.9)
Negative
190 (98.9)
40 (100.0)
228 (99.1)
Powassan virus
Positive01 (2.5)1 (0.4)
Negative190 (100.0)39 (97.5)229 (99.6)

*Database persons refers to tick-bitten persons who had submitted their ticks to a tick identification program in Maine. Family of database persons were database person family members who reported being bitten by a blacklegged tick during 2009–2013.

*Database persons refers to tick-bitten persons who had submitted their ticks to a tick identification program in Maine. Family of database persons were database person family members who reported being bitten by a blacklegged tick during 2009–2013. *Database persons refers to tick-bitten persons who had submitted their ticks to a tick identification program in Maine. Family of database persons were database person family members who reported being bitten by a blacklegged tick during 2009–2013.

Conclusions

Among residents of southern Maine with a history of I. scapularis tick bites, the percentage who were seropositive for B. burgdorferi was 5 times greater than that for B. miyamotoi (13.9% vs. 2.6%) and 35 times greater than the percentage of deer ticks infected with POWV (0.4%). Because our study population consisted of persons bitten by I. scapularis ticks (with engorgement ranging from slight to high), we expect seroprevalence to be greater in this group than in that of the general population. The B. burgdorferi seroprevalence of 13.9% in our study population was ≈1.5 times higher than the seroprevalence of 9.4% reported by Krause et al. () in healthy residents of southern New England. In contrast, the B. miyamotoi seroprevalence of 2.1% was comparable to the seroprevalence of 1%–3.9% reported by Krause at al. (,). Of 1,854 cases of infection with Borrelia spp. reported in Maine in 2017, a total of 1,848 were attributed to Lyme disease and only 6 (0.3%) were attributed to B. miyamotoi (). On the basis of a seroprevalence of ≈2% in this study and that B. miyamotoi might be transmitted by all tick stages, we believe that this disease is underdiagnosed in Maine (). Our population was identified by history of tick exposure, rather than by symptoms. Our results therefore represent the relative frequency of exposure to these different agents rather than risk for illness. Although the sensitivity and specificity of the 2-tier antibody assay for B. burgdorferi is better validated than those of the B. miyamotoi and POWV assays, the sensitivity and specificity of these assays are good (–). Nonetheless, our findings might represent overestimates or underestimates of actual exposure to these agents because of false-positive or false-negative results. These data provide evidence that humans are exposed to B. burgdorferi, B. miyamotoi, and POWV in Maine and help define the prevalence of human infection caused by each of these tickborne pathogens.
  12 in total

1.  Seroprevalence of Powassan virus in New England deer, 1979-2010.

Authors:  Robert A Nofchissey; Eleanor R Deardorff; Tia M Blevins; Michael Anishchenko; Angela Bosco-Lauth; Erica Berl; Charles Lubelczyk; John-Paul Mutebi; Aaron C Brault; Gregory D Ebel; Louis A Magnarelli
Journal:  Am J Trop Med Hyg       Date:  2013-04-08       Impact factor: 2.345

2.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

3.  Short report: duration of tick attachment required for transmission of powassan virus by deer ticks.

Authors:  Gregory D Ebel; Laura D Kramer
Journal:  Am J Trop Med Hyg       Date:  2004-09       Impact factor: 2.345

4.  Fatal Deer Tick Virus Infection in Maine.

Authors:  Catherine E Cavanaugh; Paul L Muscat; Sam R Telford; Heidi Goethert; William Pendlebury; Susan P Elias; Rebecca Robich; Margret Welch; Charles B Lubelczyk; Robert P Smith
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

5.  Diversity of tick species biting humans in an emerging area for Lyme disease.

Authors:  R P Smith; E H Lacombe; P W Rand; R Dearborn
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

6.  Passive surveillance in Maine, an area emergent for tick-borne diseases.

Authors:  Peter W Rand; Eleanor H Lacombe; Richard Dearborn; Bruce Cahill; Susan Elias; Charles B Lubelczyk; Geoff A Beckett; Robert P Smith
Journal:  J Med Entomol       Date:  2007-11       Impact factor: 2.278

7.  Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia.

Authors:  Alexander E Platonov; Ludmila S Karan; Nadezhda M Kolyasnikova; Natalya A Makhneva; Marina G Toporkova; Victor V Maleev; Durland Fish; Peter J Krause
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

8.  Human babesiosis, Maine, USA, 1995-2011.

Authors:  Robert P Smith; Susan P Elias; Timothy J Borelli; Bayan Missaghi; Brian J York; Robert A Kessler; Charles B Lubelczyk; Eleanor H Lacombe; Catherine M Hayes; Michael S Coulter; Peter W Rand
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

9.  Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.

Authors:  Peter J Krause; Sukanya Narasimhan; Gary P Wormser; Alan G Barbour; Alexander E Platonov; Janna Brancato; Timothy Lepore; Kenneth Dardick; Mark Mamula; Lindsay Rollend; Tanner K Steeves; Maria Diuk-Wasser; Sahar Usmani-Brown; Phillip Williamson; Denis S Sarksyan; Erol Fikrig; Durland Fish
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

10.  Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease1.

Authors:  Holly M Frost; Anna M Schotthoefer; Angela M Thomm; Alan P Dupuis; Sue C Kehl; Laura D Kramer; Thomas R Fritsche; Yvette A Harrington; Konstance K Knox
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883

View more
  8 in total

Review 1.  Powassan Virus Encephalitis.

Authors:  Anne Piantadosi; Isaac H Solomon
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

2.  Powassan Viruses Spread Cell to Cell during Direct Isolation from Ixodes Ticks and Persistently Infect Human Brain Endothelial Cells and Pericytes.

Authors:  Jonas N Conde; Santiago Sanchez-Vicente; Nicholas Saladino; Elena E Gorbunova; William R Schutt; Megan C Mladinich; Grace E Himmler; Jorge Benach; Hwan Keun Kim; Erich R Mackow
Journal:  J Virol       Date:  2021-10-13       Impact factor: 6.549

3.  Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis.

Authors:  Yan Dong; Guozhong Zhou; Wenjing Cao; Xin Xu; Yu Zhang; Zhenhua Ji; Jiaru Yang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Jing Kong; Shiyuan Wen; Bingxue Li; Peng Yue; Aihua Liu; Fukai Bao
Journal:  BMJ Glob Health       Date:  2022-06

Review 4.  Diagnostic Approach for Arboviral Infections in the United States.

Authors:  Anne Piantadosi; Sanjat Kanjilal
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

Review 5.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

6.  Tick borne relapsing fever - a systematic review and analysis of the literature.

Authors:  Ákos Jakab; Pascal Kahlig; Esther Kuenzli; Andreas Neumayr
Journal:  PLoS Negl Trop Dis       Date:  2022-02-16

7.  A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.

Authors:  Hyeree Choi; Sagar B Kudchodkar; Michelle Ho; Emma L Reuschel; Erin Reynolds; Ziyang Xu; Devivasha Bordoloi; Kenneth E Ugen; Pablo Tebas; Joseph Kim; Mohamed Abdel-Mohsen; Saravanan Thangamani; David B Weiner; Kar Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2020-10-29

8.  Powassan Virus Neuropathology and Genomic Diversity in Patients With Fatal Encephalitis.

Authors:  Erica Normandin; Isaac H Solomon; Siavash Zamirpour; Jacob Lemieux; Catherine A Freije; Shibani S Mukerji; Christopher Tomkins-Tinch; Daniel Park; Pardis C Sabeti; Anne Piantadosi
Journal:  Open Forum Infect Dis       Date:  2020-08-29       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.